// App-Quantinova.ai

AB0458 (2022) : DISEASE ACTIVITY AT CONCEPTION PREDICTS LUPUS FLARE UP TO 2 YEARS AFTER BIRTH: A MULTICENTRE LONG TERM FOLLOW-UP STUDY

Researchers

Presenter

  • M. Radin

Principal Investigators

  • I. Cecchi

  • F. Signorelli

  • G. De Jess

  • K. Aso

  • M. Kono

  • M. L. Urban

  • B. Bacco

  • S. Gallo Cassarino

  • L. Lo Sardo

  • S. G. Foddai

  • A. Barinotti

  • I. Gomez Garca

  • M. I. Quaglia

  • Y. Tissera

  • F. Gervasoni

  • M. . Aguirre-Zamorano

  • P. Alba

  • C. Benedetto

  • T. Atsumi

  • O. Amengual

  • G. Emmi

  • D. Andrade

  • L. Marozio

  • D. Roccatello

  • S. Sciascia

Medical Centers

  • University of Turin, Clinical and Biological Sciences, Turin, Italy

  • Guy’s and St Thomas’ Hospital, Department of Thrombosis and Haemophlia, London, United Kingdom

  • Universidade Federal do Estado do Rio de Janeiro, Neurology, Rio de Janeiro, Brazil

  • Hokkaido University, Department of Rheumatology, Endocrinology and Nephrology, Sapporo, Japan

  • University of Florence, Department of Experimental and Clinical Biomedical Sciences, Florence, Italy

  • University of Cordoba, Rheumatology Service, Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Cordoba, Spain

  • Universidad Nacional de Córdoba, Hospital Córdoba and Materno Neonatal, Cordoba, Argentina

Locations

  • Italy

  • United Kingdom

  • Brazil

  • Japan

  • Spain

  • Argentina

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Multicenteric

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved